A new Periodic Transaction Report filed under the STOCK Act shows that Rep. April McClain Delaney’s dependent child sold shares of Nasdaq, Inc. common stock (ticker: NDAQ) on August 25, 2026. The disclosure lists the transaction value in the $100,001 to $250,000 range, placing it among the mid-sized sales members of Congress and their families are required to report.
Under the STOCK Act, members of Congress and their immediate family members must disclose transactions in individual stocks within 45 days of execution. This filing meets that requirement and does not, on its own, indicate any wrongdoing or special knowledge on the part of Rep. McClain Delaney or her family. Members of Congress and their dependents buy and sell securities for many personal financial reasons unrelated to legislative activity.
A Notable Timing Overlap
What makes this filing stand out is its proximity to another sale of the same stock. Company insider Jeremy Skule sold NDAQ shares worth $213,188 on August 10, 2026 — just 15 days before the McClain Delaney family’s disclosed sale. Both transactions fall within a tight 30-day window, a pattern that whoisbuyingnow.com flags for readers tracking overlapping activity between corporate insiders and congressional trading disclosures.
It is important to be precise about what this overlap does and does not show. There is no disclosed connection between Rep. McClain Delaney’s family transaction and Jeremy Skule’s sale as a Nasdaq insider. The two filings are separate legal disclosures made under different regulatory frameworks — one under the STOCK Act for members of Congress, the other under insider-trading reporting rules that apply to corporate executives and affiliates. Their timing alignment is being noted here purely as a data point, not as evidence of coordination.
Why It’s Being Tracked
Nasdaq, Inc. itself operates the exchange infrastructure underlying much of the U.S. equity market, making any cluster of insider and congressional trading activity around its stock a point of interest for transparency-focused observers. Readers following whoisbuyingnow.com’s congressional trading tracker will see this sale logged as a ‘congress sale’ signal, cross-referenced against the Skule insider transaction for context.
As with all STOCK Act disclosures, this report reflects a legal filing obligation rather than a statement about investment merit. The underlying reasons for the sale — whether portfolio rebalancing, liquidity needs, or another personal factor — are not disclosed in the filing itself, and none should be assumed.